In vivo selection of hematopoietic progenitor cells and temozolomide dose intensification in rhesus macaques through lentiviral transduction with a drug resistance gene

Journal of Clinical Investigation

Volumn 119, Issue 7, 2009, Pages 1952-1963

  Larochelle, Andre ^a   Choi, Uimook ^b   Shou, Yan ^c   Naumann, Nora ^b   Loktionova, Natalia A ^d   Clevenger, Joshua R ^a   Krouse, Allen ^a   Metzger, Mark ^a   Donahue, Robert E ^a   Kang, Elizabeth ^b   Stewart, Clinton ^c   Persons, Derek ^c   Malech, Harry L ^b   Dunbar, Cynthia E ^a   Sorrentino, Brian P ^c  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CARMUSTINE; DACARBAZINE; GUANINE; HOMEODOMAIN PROTEIN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; O(6)-BENZYLGUANINE; TEMOZOLOMIDE;

ANALOGS AND DERIVATIVES; ANIMAL; GENE THERAPY; GENE VECTOR; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LENTIVIRINAE; PHYSIOLOGY; RHESUS MONKEY;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CARMUSTINE; DACARBAZINE; GENETIC THERAPY; GENETIC VECTORS; GUANINE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOMEODOMAIN PROTEINS; LENTIVIRUS; MACACA MULATTA; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE;

EID: 68849096855     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/jci37506     Document Type: Article

References (63)

1. Nienhuis, A.W., Dunbar, C.E., and Sorrentino, B.P. 2006. Genotoxicity of retroviral integration in hematopoietic cells. Mol. Ther. 13:1031-1049.
2. Nienhuis, A.W. 2008. Development of gene therapy for blood disorders. Blood. 111:4431-4444.
3. Ferguson, C., Larochelle, A., and Dunbar, C.E. 2005. Hematopoietic stem cell gene therapy: dead or alive? Trends Biotechnol. 23:589-597.
4. Horn, P.A., Morris, J.C., Neff, T., and Kiem, H.P. 2004. Stem cell gene transfer--efficacy and safety in large animal studies. Mol. Ther. 10:417-431.
5. Cavazzana-Calvo, M., et al. 2000. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science. 288:669-672.
6. Neff, T., Beard, B.C., and Kiem, H.P. 2006. Survival of the fittest: in vivo selection and stem cell gene therapy. Blood. 107:1751-1760.
7. Podda, S., et al. 1992. Transfer and expression of the human multiple drug resistance gene into live mice. Proc. Natl. Acad. Sci. U. S. A. 89:9676-9680.
8. Sorrentino, B.P., et al. 1992. Selection of drug resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science. 257:99-103.
9. Allay, J.A., et al. 1998. In vivo selection of retrovirally transduced hematopoietic stem cells. Nat. Med. 4:1136-1143.
10. Davis, B.M., Koc, O.N., and Gerson, S.L. 2000. Limiting numbers of G156A O(6)-methylguanine-DNA methyltransferase-transduced marrow progenitors repopulate nonmyeloablated mice after drug selection. Blood. 95:3078-3084.
11. Ragg, S., et al. 2000. Direct reversal of DNA damage by mutant methyltransferase protein protects mice against dose-intensified chemotherapy and leads to in vivo selection of hematopoietic stem cells. Cancer Res. 60:5187-5195.
12. Sawai, N., et al. 2001. Protection and in vivo selection of hematopoietic stem cells using temozolomide, O(6)-benzylguanine, and an alkyltransferaseexpressing retroviral vector. Mol. Ther. 3:78-87.
13. Persons, D.A., et al. 2004. Transient in vivo selection of transduced peripheral blood cells using antifolate drug selection in rhesus macaques that received transplants with hematopoietic stem cells expressing dihydrofolate reductase vectors. Blood. 103:796-803.
14. Hibino, H., et al. 1999. The common marmoset as a target preclinical primate model for cytokine and gene therapy studies. Blood. 93:2839-2848.
15. Licht, T., et al. 2002. Drug selection with paclitaxel restores expression of linked IL-2 receptor gamma-chain and multidrug resistance (MDR1) transgenes in canine bone marrow. Proc. Natl. Acad. Sci. U. S. A. 99:3123-3128.
16. Crone, T.M., Kanugula, S., and Pegg, A.E. 1995. Mutations in the Ada O6-alkylguanine-DNA alkyltransferase conferring sensitivity to inactivation by O6-benzylguanine and 2,4-diamino-6-benzyloxy-5-nitrosopyrimidine. Carcinogenesis. 16:1687-1692.
17. Loktionova, N.A., Xu-Welliver, M., Crone, T.M., Kanugula, S., and Pegg, A.E. 1999. Protection of CHO cells by mutant forms of O6-alkylguanine-DNA alkyltransferase from killing by 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) plus O6-benzylguanine or O6-benzyl-8-oxoguanine. Biochem. Pharmacol. 58:237-244.
18. Gerull, S., Beard, B.C., Peterson, L.J., Neff, T., and Kiem, H.P. 2007. In vivo selection and chemoprotection after drug resistance gene therapy in a nonmyeloablative allogeneic transplantation setting in dogs. Hum. Gene Ther. 18:451-456.
19. Neff, T., et al. 2003. Methylguanine methyltransferase-mediated in vivo selection and chemoprotection of allogeneic stem cells in a large-animal model. J. Clin. Invest. 112:1581-1588.
20. Neff, T., et al. 2005. Polyclonal chemoprotection against temozolomide in a large-animal model of drug resistance gene therapy. Blood. 105:997-1002.
21. Pollok, K.E., et al. 2003. In vivo selection of human hematopoietic cells in a xenograft model using combined pharmacologic and genetic manipulations. Hum. Gene Ther. 14:1703-1714.
22. Zielske, S.P., Reese, J.S., Lingas, K.T., Donze, J.R., and Gerson, S.L. 2003. In vivo selection of MGMT(P140K) lentivirus-transduced human NOD/SCID repopulating cells without pretransplant irradiation conditioning. J. Clin. Invest. 112:1561-1570.
23. Stupp, R., et al. 2005. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352:987-996.
24. Perkins, A.C., and Cory, S. 1993. Conditional immortalization of mouse myelomonocytic, megakaryocytic and mast cell progenitors by the Hox-2.4 homeobox gene. EMBO J. 12:3835-3846.
25. Sauvageau, G., et al. 1995. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev. 9:1753-1765.
26. Antonchuk, J., Sauvageau, G., and Humphries, R.K. 2002. HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell. 109:39-45.
27. Zhang, X.B., et al. 2006. Differential effects of HOXB4 on nonhuman primate short- and longterm repopulating cells. PLoS Med. 3:e173.
28. Sawai, N., Persons, D.A., Zhou, S., Lu, T., and Sorrentino, B.P. 2003. Reduction in hematopoietic stem cell numbers with in vivo drug selection can be partially abrogated by HOXB4 gene expression. Mol. Ther. 8:376-384.
29. Panetta, J.C., et al. 2003. Population pharmacokinetics of temozolomide and metabolites in infants and children with primary central nervous system tumors. Cancer Chemother. Pharmacol. 52:435-441.
30. Quinn, J.A., et al. 2005. Phase I trial of temozolomide plus O6-benzylguanine for patients with recurrent or progressive malignant glioma. J. Clin. Oncol. 23:7178-7187.
31. Hematti, P., et al. 2004. Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells. PLoS Biol. 2:e423.
32. Mitchell, R.S., et al. 2004. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol. 2:E234.
33. Bushman, F., et al. 2005. Genome-wide analysis of retroviral DNA integration. Nat. Rev. Microbiol. 3:848-858.
34. Kim, Y.J., et al. 2009. Sustained high level polyclonal hematopoietic marking and transgene expression four years following autologous transplantation of rhesus macaques with SIV lentiviral vector transduced CD34+ cells. Blood. Online publication ahead of print. doi:10.1182/blood-2008-10- 185199.
35. Milsom, M.D., et al. 2008. Reciprocal relationship between O6-methylguanine-DNA methyltransferase P140K expression level and chemoprotection of hematopoietic stem cells. Cancer Res. 68:6171-6180.
36. Hanawa, H., et al. 2004. Extended beta-globin locus control region elements promote consistent therapeutic expression of a gamma-globin lentiviral vector in murine beta-thalassemia. Blood. 104:2281-2290.
37. Hanawa, H., Persons, D.A., and Nienhuis, A.W. 2002. High-level erythroid lineage-directed gene expression using globin gene regulatory elements after lentiviral vector-mediated gene transfer into primitive human and murine hematopoietic cells. Hum. Gene Ther. 13:2007-2016.
38. Persons, D.A., et al. 2003. Successful treatment of murine beta-thalassemia using in vivo selection of genetically modified, drug-resistant hematopoietic stem cells. Blood. 102:506-513.
39. Hong, S., et al. 2007. Functional analysis of various promoters in lentiviral vectors at different stages of in vitro differentiation of mouse embryonic stem cells. Mol. Ther. 15:1630-1639.
40. Wang, L., Haas, D., Halene, S., and Kohn, D. 2003. Effects of the negative control region on expression from retroviral LTR. Mol. Ther. 7:438-439.
41. Challita, P.M., et al. 1995. Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells. J. Virol. 69:748-755.
42. Robbins, P.B., et al. 1997. Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells. J. Virol. 71:9466-9474.
43. Halene, S., et al. 1999. Improved expression in hematopoietic and lymphoid cells in mice after transplantation of bone marrow transduced with a modified retroviral vector. Blood. 94:3349-3357.
44. Lois, C., Hong, E.J., Pease, S., Brown, E.J., and Baltimore, D. 2002. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science. 295:868-872.
45. Shepherd, B.E., et al. 2007. Hematopoietic stemcell behavior in nonhuman primates. Blood. 110:1806-1813.
46. Abkowitz, J.L., Golinelli, D., Harrison, D.E., and Guttorp, P. 2000. In vivo kinetics of murine hemopoietic stem cells. Blood. 96:3399-3405.
47. Zhou, S., et al. 2001. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med. 7:1028-1034.
48. Bunting, K.D. 2002. ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells. 20:11-20.
49. Moreb, J.S. 2008. Aldehyde dehydrogenase as a marker for stem cells. Curr. Stem Cell Res. Ther. 3:237-246.
50. Hess, D.A., et al. 2004. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood. 104:1648-1655.
51. Sung, L.Y., et al. 2006. Differentiated cells are more efficient than adult stem cells for cloning by somatic cell nuclear transfer. Nat. Genet. 38:1323-1328.
52. Thorsteinsdottir, U., et al. 1997. Overexpression of HOXA10 in murine hematopoietic cells perturbs both myeloid and lymphoid differentiation and leads to acute myeloid leukemia. Mol. Cell Biol. 17:495-505.
53. Zhang, X.B., et al. 2008. High incidence of leukemia in large animals after stem cell gene therapy with a HOXB4-expressing retroviral vector. J. Clin. Invest. 118:1502-1510.
54. Larochelle, A., et al. 2006. AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates. Blood. 107:3772-3778.
55. Donahue, R.E., et al. 1996. Peripheral blood CD34+ cells differ from bone marrow CD34+ cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or non mobilized with granulocyte colony-stimulating factor and/or stem cell factor. Blood. 87:1644-1653.
56. Dunbar, C.E., et al. 1996. Improved retroviral gene transfer into murine and rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor. Proc. Natl. Acad. Sci. U. S. A. 93:11871-11876.
57. Hanawa, H., et al. 2004. Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system. Blood. 103:4062-4069.
58. Choi, U., et al. 2004. Nuclear-localizing O6-benzylguanine-resistant GFP-MGMT fusion protein as a novel in vivo selection marker. Exp. Hematol. 32:709-719.
59. Szymczak, A.L., et al. 2004. Correction of multigene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector. Nat. Biotechnol. 22:589-594.
60. Karolchik, D., et al. 2007. Comparative genomic analysis using the UCSC genome browser. Methods Mol. Biol. 395:17-34.
61. Kent, W.J. 2002. BLAT - the BLAST-like alignment tool. Genome Res. 12:656-664.
62. Futreal, P.A., et al. 2004. A census of human cancer genes. Nat. Rev. Cancer. 4:177-183.
63. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.